Your search

Lipedema and obesity are chronic, frequently progressive disorders that can present with increased adipose-tissue volume, functional impairment and reduced quality of life. Although often approached as differential diagnoses, they frequently coexist and may aggravate one another. This narrative review addresses how lipedema and obesity interact biologically and clinically and what evidence supports a staged interdisciplinary approach to diagnosis and management. Obesity is increasingly conceptualized as an adiposity-based chronic disease characterized by excess adipose, abnormal adipose-tissue distribution or dysfunction, and associated medical or functional impairment. Obesity can impair lymphatic morphology and function, whereas lymphatic dysfunction may promote subcutaneous adipose-tissue expansion and fibrosis. Literature was identified through iterative PubMed searches and focused supplementary searches in Embase and the Cochrane Library. Publications were selected purposively for their relevance to predefined clinical and mechanistic domains; no systematic screening or formal risk-of-bias assessment was performed. This review synthesizes clinical overlap, biological evidence, diagnostic implications, and staged management for predominantly adult women with suspected or confirmed lipedema, including those with coexisting overweight or obesity. The proposed framework is intended to support clinical reasoning rather than serve as a formal guideline.

PURPOSE: Individuals with lipoedema may experience negative impacts that are not often identified through current quality-of-life measures. The aim of this study was to explore the experiences of individuals living with pre-existing lipoedema and their perceptions of how these experiences influence quality of life. METHODS: Participants with a prior diagnosis of lipoedema participated in a single semi-structured interview or focus group. These interviews/focus groups were transcribed verbatim, allowing for an inductive thematic analysis to be conducted. RESULTS: Sixteen participants were included and four main themes were identified. These included: the ongoing work of living with lipoedema, living with a restrictive and overwhelming condition, caught between self-acceptance and social judgement, and forced to navigate lipoedema alone. Across the four themes, 21 sub-themes emerged to convey the quality-of-life concerns experienced by individuals with lipoedema. CONCLUSIONS: Individuals living with lipoedema experience impacts on their quality-of-life across physical, psychological, and social aspects of life. This study highlights how the ongoing burden of physical symptoms, social perceptions, and healthcare-related challenges contributes to reduced quality-of-life for individuals living with lipoedema. Increased knowledge and awareness amongst healthcare providers is needed to improve care received by individuals living with this condition.

IntroductionLipedema is a chronic adipose and connective tissue disorder in which pain is classically localized to affected limb tissue. However, some patients report joint, periarticular, myotendinous, or axial pain, with fatigue, sleep disturbance, and exercise intolerance. When symptoms become widespread, the presentation may resemble fibromyalgia (FM), creating a diagnostic challenge for phlebologists.ObjectivesTo provide a clinical framework for distinguishing characteristic lipedema tissue pain from musculoskeletal pain generators, secondary central pain amplification, and potentially coexisting FM.MethodsThis narrative review was conducted with reference to the Scale for the Assessment of Narrative Review Articles (SANRA). PubMed, Scopus, and Google Scholar were searched through May 2026 for studies addressing lipedema, FM, widespread pain, hypermobility, connective tissue vulnerability, biomechanical dysfunction, and pain sensitization. Reference lists were manually screened. No formal risk-of-bias assessment or quantitative synthesis was performed.ResultsCharacteristic lipedema pain is predominantly localized to affected adipose tissue and associated with tenderness, pressure sensitivity, easy bruising, and functional impairment. Observational studies have also reported joint and periarticular pain, axial symptoms, hypermobility, and biomechanical dysfunction in patient subsets. Extra-adipose pain should be assessed separately and not automatically attributed either to lipedema or independent FM. Tissue hypersensitivity, stromal and microvascular alterations, joint instability, and altered biomechanics may represent peripheral pain generators contributing to secondary central amplification. However, observational evidence does not establish whether widespread pain is intrinsic to lipedema, secondary to musculoskeletal dysfunction or central amplification, or reflects coexisting FM.ConclusionsIn patients with lipedema and extra-adipose or widespread pain, phlebologists should assess joint hypermobility, instability, biomechanical dysfunction, and axial or musculoskeletal pain. FM criteria identify a widespread pain phenotype but cannot determine whether it represents an independent comorbidity or is related to persistent peripheral nociceptive mechanisms. Multidisciplinary assessment may improve diagnostic characterization and individualized management.

BackgroundChronic venous disorders and lipedema are complex and frequently underdiagnosed conditions characterized by heterogeneous clinical presentations, progressive tissue remodeling, and substantial variability in treatment response assessment. Despite advances in minimally invasive vascular interventions, longitudinal evaluation in routine clinical practice continues to rely heavily on subjective interpretation, non-standardized comparative imaging, and physician-dependent assessment pathways. The integration of multimodal vascular data into structured longitudinal clinical workflows remains limited.ObjectiveThis study introduces the LipoVena AI Framework, a physician-centered conceptual artificial intelligence-assisted clinical support architecture designed to facilitate multimodal integration, longitudinal treatment-response evaluation, and personalized monitoring in lipedema and chronic venous disease management.MethodsA retrospective observational clinical dataset consisting of 32 patients with chronic venous insufficiency, lipedema, reticular veins, spider veins, and mixed venous-lymphatic phenotypes was reviewed. Standardized standing-position photography, duplex ultrasound imaging, procedural documentation, and longitudinal 1-month follow-up assessments were integrated within a conceptual AI-assisted workflow. Representative patients underwent multimodal minimally invasive treatment strategies including endovenous laser therapy (EVLT), CLACS-guided sclerotherapy, radiofrequency-based tissue remodeling, and compression therapy. The proposed framework conceptually integrates multimodal imaging analysis, vascular mapping, comparative longitudinal assessment, and physician-supervised AI-assisted interpretation.ResultsRepresentative 1-month follow-up observations demonstrated visible improvements in contour harmonization, superficial venous prominence, tissue irregularity, skin texture uniformity, and vascular burden across multiple venous and lipedema phenotypes. Comparative multimodal analysis integrating clinical photography and duplex ultrasound findings enabled structured longitudinal assessment of therapeutic response patterns. Upper-extremity lipedema cases additionally demonstrated measurable contour and tissue-texture improvement following multimodal treatment strategies. The proposed framework illustrated the potential role of AI-assisted longitudinal comparison and multimodal integration in supporting objective treatment-response evaluation within physician-centered vascular care workflows.ConclusionThe LipoVena AI Framework presents a conceptual translational model for future AI-assisted vascular and lipedema medicine by integrating standardized clinical imaging, duplex ultrasound evaluation, multimodal treatment documentation, and longitudinal follow-up analysis within a physician-centered ecosystem. Although prospective multicenter validation and quantitative AI modeling remain necessary, the present framework highlights the potential of explainable and physician-supervised artificial intelligence systems to support personalized, data-driven, and longitudinally optimized vascular care.

RATIONALE: To evaluate which factors are associated with change in lymphedema-specific quality of life (QoL) and relative volume difference in the maintenance phase after a multidisciplinary intensive treatment program in patients with lower limb lymphedema(LLL). METHODS AND RESULTS: In this retrospective study, patients received a multidisciplinary intensive treatment followed by a maintenance phase. In this maintenance phase, patients were advised to perform skin care and exercises and to wear compression garments. Circumferential measurements and the Lymph-ICF-LL questionnaires to determine volume and the lymphedema-specific QoL, respectively, were collected at the start and end of the intensive treatment and at 6 months follow-up. Patient-, lymphedema-, and treatment-related variables were collected to investigate their association with change in lymphedema-specific QoL and relative volume in the maintenance phase. Mann-Whitney U and Spearman rank correlation tests were applied. Patients (n = 279) who did not receive physiotherapy between 5 and 6 months follow-up and had a lower %score on the 6-minute walk test at the start of the intensive treatment showed significant better improvement in physical function and general tasks/household in the maintenance phase, respectively. Younger age, concomitant lipedema, and a lower % volume reduction during intensive treatment were significantly associated with less relative volume increase in the maintenance phase. CONCLUSIONS: Patients without physiotherapy around 5-6 months follow-up or with limited physical capacity at the start may perceive better improvements in certain lymphedema-specific QoL domains, while younger age, concomitant lipedema, and less initial volume reduction appear to be less predisposed to volume regain during the maintenance phase.

Rare adipose disorders are abnormal subcutaneous adipose tissue diseases that present as a spectrum of soft tissue abnormalities that may be encountered by plastic surgeons. Presentation ranges from distinct subcutaneous masses in characteristic distributions in the body to large generalized fatty deposits. It is imperative to recognize these rare adipose disorders, as they are typically refractory to standard treatment approaches to obesity, such as weight loss, lifestyle modifications, pharmacologic therapy, and bariatric surgery. In this review, we provide a complete and updated review of lipedema, Madelung disease, familial multiple lipomatosis, and Dercum’s disease as well as present a case series highlighting our surgical approach to rare adipose disorders.

This Letter to the Editor documents several verifiable internal inconsistencies in the article by Bruno and D’Antimi, including contradictory statements on study design, a level-of-evidence rating incompatible with the stated methods, contradictory informed-consent statements, and references to a procedure and outcome domain that do not correspond to the study performed. A correction or clarification is requested.

BackgroundLipedema is a chronic condition that predominantly affects women and is commonly associated with pain, edema, and functional impairment. Conservative physiotherapy interventions are frequently recommended; however, the scope and characteristics of the available evidence remain unclear.ObjectiveTo map the existing evidence on conservative physiotherapy interventions for lipedema, focusing on intervention types, outcomes assessed, and methodological characteristics.MethodsA scoping review was conducted according to the PRISMA-ScR guidelines. Eligibility was guided by the PCC framework. Electronic databases and gray literature were searched for primary studies and secondary sources addressing conservative physiotherapy interventions for lipedema. Data were synthesized descriptively.Results15 records were included, comprising randomized controlled trials, observational studies, and secondary sources such as reviews, guidelines, and consensus documents. The most frequently investigated interventions were complex decongestive therapy, therapeutic compression, structured exercise programs, and adjunct physical modalities. Outcomes mainly included edema, pain, functional capacity, and quality of life. Among primary studies, multimodal conservative physiotherapy approaches were the most frequently reported. Secondary sources consistently described conservative physiotherapy as a component of care, although they were not treated as independent confirmation of treatment effects.ConclusionThe available literature suggests that conservative physiotherapy is frequently described as a component of lipedema management. However, the evidence base is characterized by methodological heterogeneity, small sample sizes, and the absence of formal quality appraisal, and the findings should be interpreted as a mapping of the available evidence rather than as evidence of treatment efficacy.

Timely diagnosis of lipoedema remains challenging, with prolonged delays contributing to reduced quality of life. The aim of this study was to analyse the time from first symptom onset to diagnosis, and identify factors associated with diagnostic intervals.

ObjectivesTo investigate the clinical and ultrasonographic changes associated with radial extracorporeal shock wave therapy (rESWT) in women with lipedema.MethodsThis prospective, single-arm study included 40 women with lipedema who completed six sessions of rESWT administered twice weekly to the index lower limb. Treatment consisted of 3000-6000 impulses at 15 Hz and 3-4 bar. Participants were evaluated at baseline (T0), immediately after treatment (T1), and at 4-week follow-up (T2). Outcomes included visual analog scale (VAS) pain scores, Patient-Reported Outcomes Measurement Information System (PROMIS) scores, pressure pain threshold (PPT), limb circumference, subcutaneous fat thickness (SCFT), and tissue echogenicity. Patient Global Impression of Change (PGIC) was assessed at T1 and T2.ResultsVAS scores decreased from 8.45 at T0 to 5.45 at T1 and 4.17 at T2, while PROMIS scores decreased from 25.3 to 16.2 and 14.3, respectively (both p < .001). PPT increased significantly at all four evaluated sites (p < .001). Calf and thigh circumferences decreased significantly over time (both p < .001). Medial calf SCFT decreased from 16.5 to 15.2 and 15.1 mm, and medial thigh SCFT from 21.0 to 18.2 and 18.1 mm (both p < .001). Median tissue echogenicity decreased from 3 at baseline to 2 at both post-treatment assessments (p < .001). PGIC scores also improved between T1 and T2 (p < .001).ConclusionsSix sessions of rESWT were associated with improvements in pain, quality of life, mechanical pain sensitivity, limb circumference, and ultrasonographic tissue characteristics in women with lipedema, with most improvements maintained at 4-week follow-up. These findings support further evaluation of rESWT as an adjunctive conservative treatment for lipedema in controlled studies with longer follow-up.Trial registrationClinicalTrials.gov, NCT07683559.

ObjectivesLipedema is a chronic adipose tissue disorder characterized by disproportionate fat accumulation, lower extremity pain, functional impairment, and reduced quality of life. Although pain is a cardinal symptom, its underlying mechanisms remain incompletely understood. This study aimed to characterize sensitization-related pain phenotypes in women with lipedema by examining central sensitization (CS) and neuropathic -like pain features and their associations with lower extremity function, sleep quality, and health-related quality of life (HRQoL).MethodsIn this cross-sectional case-control study, 54 women with clinically diagnosed lipedema and 48 age-matched control participants were enrolled between March and October 2025. Pain phenotypes were assessed using the Central Sensitization Inventory (CSI) and Pain-DETECT questionnaire. Lower extremity function, sleep quality, and HRQoL were evaluated using Lower Extremity Functional Scale (LEFS), Jenkins Sleep Scale (JSS), and EuroQol-5D-3L (EQ-5D-3L), respectively.ResultsWomen with lipedema had significantly higher Pain-DETECT and CSI scores than controls, indicating greater neuropathic-like pain features and CS-related symptom burden (both p < .01). They also demonstrated poorer lower extremity function, greater sleep disturbance, and lower HRQoL. Pain-DETECT scores were positively correlated with CSI, anxiety, depression, and sleep disturbance scores. In multivariable analyses, LEFS independently predicted Pain-DETECT scores (B = -0.171, p = .015), whereas anxiety independently predicted CSI scores (B = 1.980, p = .002).ConclusionsWomen with lipedema exhibit prominent sensitization-related pain phenotypes associated with functional impairment, sleep disturbances, and reduced quality of life. Identification of these pain characteristics may improve clinical assessment, patient stratification, and multidisciplinary management of lower extremity symptoms in lipedema.

ObjectivesTo determine the prevalence of chronic venous insufficiency (CVI) in patients with lipedema, characterize venous reflux patterns and CEAP clinical classes, and evaluate associations with demographic and lipedema-related characteristics.MethodsThis retrospective, single-center observational study included adults with lipedema evaluated between January 2023 and December 2025. Of 120 patients screened, 50 were excluded because of incomplete venous Doppler ultrasonography, clinical, or demographic data, leaving 70 patients for analysis. Demographic and clinical characteristics and lower-extremity venous duplex ultrasonography findings were reviewed. Superficial, deep, and perforator reflux; segment-specific reflux; great saphenous vein (GSV) and small saphenous vein (SSV) diameters; laterality; and CEAP clinical class were recorded. Pathological reflux was defined as reversed flow lasting >0.5 s in superficial truncal veins and >1.0 s in the common femoral, femoral, and popliteal veins. Univariable and multivariable logistic regression analyses examined factors associated with CVI.ResultsCVI was identified in 38 of 70 patients (54.3%; 95% confidence interval, 41.9%-66.3%). Venous reflux predominantly involved the superficial system, with GSV reflux as the most frequent segment-specific finding, whereas deep venous reflux was uncommon. Patients with CVI had greater GSV and SSV diameters than those without CVI (both p < 0.001), while age, body mass index (BMI), and disease duration did not differ between groups. CVI frequency increased across BMI categories, although the overall categorical association was not significant. Lipedema stage was not associated with CVI or individual reflux patterns; however, increasing lipedema stage showed a weak positive association with higher CEAP clinical class. Age, BMI, and lipedema stage were not independently associated with CVI in multivariable analysis.ConclusionsVenous insufficiency was frequently observed in patients with lipedema and predominantly involved the superficial venous system. Greater saphenous vein diameters provided an objective ultrasonographic correlate of venous involvement. Because an appropriately matched local control population was not available, the present study cannot establish whether venous reflux is more frequent in patients with lipedema than in the general population. The observed relationship between lipedema stage and CEAP clinical class should therefore be considered hypothesis-generating and warrants confirmation in prospective controlled studies.

ObjectiveThis study aimed to comparatively evaluate sleep quality in individuals with lipedema and healthy controls. In addition, the relationships between sleep quality and depression, anxiety, fatigue, and clinical parameters were investigated.MethodsThis cross-sectional study included 30 women with lipedema and 30 healthy female controls aged 18-75 years. Pain severity in individuals with lipedema was assessed using the Visual Analog Scale (VAS). Lipedema stage, comorbidities, and symptom duration were also recorded. Sleep quality was evaluated using the Pittsburgh Sleep Quality Index (PSQI), depressive and anxiety-related symptoms were assessed using the Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI), and fatigue severity was evaluated using the Fatigue Severity Scale (FSS).ResultsIndividuals with lipedema had significantly higher BDI, BAI, and FSS scores than controls (all p < 0.001 except BDI, p = 0.001). Sleep quality was significantly poorer in the lipedema group (p < 0.001). Among PSQI subcomponents, subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, and daytime dysfunction were significantly worse in individuals with lipedema, while sleep medication use was similar between groups (p > 0.05). In the lipedema group, PSQI scores were positively correlated with depressive (r = 0.489, p = 0.006) and anxiety symptoms (r = 0.386, p = 0.035). No significant associations were found between sleep quality and age, anthropometric measurements, education duration, pain severity, lipedema stage, symptom duration, or fatigue severity.ConclusionsThis study demonstrated poorer sleep quality in individuals with lipedema compared to healthy controls. Sleep quality was also associated with depressive and anxiety-related symptoms, highlighting an association between psychological symptoms and sleep problems in individuals with lipedema.

Lipedema is a chronic disorder of adipose tissue marked by disproportionate fat accumulation in the extremities and persistent pain, which significantly impairs quality of life. Although liposuction has been adopted as a therapeutic intervention beyond aesthetic purposes, the extent and long-term persistence of pain reduction after surgery have not been fully quantified.

BackgroundThere are no validated Norwegian disease-specific patient-reported outcome measures (PROMs) assessing quality of life (QoL) in females with lipedema, limiting evaluation of treatment effect in clinical practice and research.ObjectiveTo translate and validate a Norwegian translation of the LIPQOL questionnaire.MethodsA cross-sectional validation study was performed in 432 females with lipedema in Norway. Descriptive statistics and floor and ceiling effects were assessed. The psychometric properties of the questionnaire were assessed using confirmatory factor analysis (CFA). The overall goodness of fit was evaluated using the root mean square error of approximation (RMSEA), the comparative fit index (CFI) and the Tucker–Lewis index (TLI). Internal consistency was assessed using composite reliability from the CFA. Associations between LIPQOL subscales and RAND-12 physical component score (PCS) and mental component score (MCS) were examined using Spearman correlations.ResultsThe LIPQOL questionnaire comprises four subscales, Function, Body image, Symptoms, and Feelings. No subscales was affected by floor or ceiling effects. The unmodified CFA shows CFI = 0.929, TLI = 0.922, standardized root mean square residual (SRMR) = 0.073, and RMSEA = 0.079 (90% CI: 0.073 to 0.084). All composite reliability were considered reasonable (ranged from 0.890 to 0.916). Modification indices were evaluated, and two modifications were performed between items 5 and 8, and between items 17 and 18. With modification indices, the overall structure validity showed reasonable, but not unequivocally support for the four factor structure with CFI = 0.944, and TLI = 0.938, SRMR = 0.068, and RMSEA = 0.070 (90% CI: 0.064 to 0.075). Correlation between RAND-12 and LIPQOL subscales were large. Function, Symptoms, and overall quality of life show large correlation with PCS (Spearman's rho = −0.682, Spearman's rho = −0.550, and Spearman's rho = 0.554, respectively) and the subscales feelings and overall quality of life shows large correlation with MCS from RAND-12 (Spearman's rho = −0.685 and 0.608, respectively).ConclusionInitial findings suggest that the Norwegian version of the LIPQOL is a reasonably valid instrument for assessing quality of life in females with lipedema, although the findings do not provide unequivocal support for all aspects of its measurement properties.

ObjectivesThis study aimed to determine the frequency of probable lipedema among women with lower extremity pain (LEP) using a validated screening questionnaire and to examine its associations with neuropathic pain (NP) characteristics, functional status, psychological symptoms, and health-related quality of life (HRQoL).MethodsThis prospective questionnaire-based case-control study included 133 women, comprising 68 women with LEP and 65 age-matched healthy controls. Participants were evaluated using the Lipedema Screening Questionnaire (LSQ), Lower Extremity Functional Scale (LEFS), Hospital Anxiety and Depression Scale (HADS), PainDETECT questionnaire, and 12-Item Short Form Health Survey (SF-12). An LSQ score of ≥8 was classified as probable lipedema, whereas a score of ≥12 was classified as high-probability lipedema. These categories indicate screening probability rather than a confirmed clinical diagnosis of lipedema. Group comparisons, correlation analyses, and multivariable regression analyses were performed to examine factors associated with LSQ and LEFS scores.ResultsWomen with LEP had significantly higher LSQ scores and a greater proportion of probable lipedema (36.8% vs 12.3%, p = .001) and high-probability lipedema (19.1% vs 3.1%, p = .003) than controls. Compared with controls, women with LEP had poorer lower extremity function, greater anxiety symptoms, more prominent NP characteristics, and lower physical and mental HRQoL scores (all p < .05). Higher LSQ scores were positively correlated with PainDETECT scores (r = 0.446, p < .001), whereas pain intensity was not significantly correlated with the evaluated clinical outcomes. In multivariable linear regression, PainDETECT score was independently associated with LSQ score (β = 0.382, p = .004). For functional status, both the SF-12 physical (β = 0.352, p = .001) and mental component scores (β = 0.362, p = .002) were independently associated with LEFS scores.ConclusionsProbable lipedema was more frequently identified by LSQ among women with LEP than among healthy controls. NP characteristics were independently associated with greater lipedema-related symptom burden, whereas lower extremity function was independently associated with both physical and mental HRQoL. These findings support the use of lipedema and NP screening as complementary components of the clinical assessment of women with LEP. However, LSQ findings should not be interpreted as a clinical diagnosis of lipedema and require confirmation through appropriate clinical assessment.

Validation and reliability of the Turkish version of the lipedema screening questionnaire - Turkish Journal of Physical Medicine and Rehabilitation

Background/Objectives: Lipedema is an adipose tissue disorder associated with body-related burden. This study compared orthorexic eating tendencies between women with and without lipedema and examined associations with body-shape concern and psychological symptoms. Methods: This controlled cross-sectional study included 44 women with lipedema and 44 women without lipedema. Participants completed the Düsseldorf Orthorexia Scale (DOS), Body Shape Questionnaire (BSQ), and Hospital Anxiety and Depression Scale (HADS). Associated variables were examined using multiple linear regression. Results: Women with lipedema had higher DOS scores than women without lipedema (25.07 ± 6.55 vs. 20.48 ± 5.05; Cohen's d = 0.79; p < 0.001). BSQ, HADS-Anxiety, and HADS-Depression scores were also higher in the lipedema group (all p ≤ 0.001). DOS and BSQ scores were positively correlated in both groups. In the multivariable model, which included group status, age, BMI, BSQ, HADS-A, and HADS-D scores, BSQ score was independently associated with DOS score (B = 0.067; 95% CI 0.025-0.108; p = 0.002), whereas group status and the other covariates were not. The model's adjusted R2 was 0.234. Conclusions: Women with lipedema exhibited greater orthorexic eating tendencies, body-shape concern, and psychological symptoms than controls. Body-shape concern was independently associated with orthorexic eating tendencies. The group difference in DOS scores is largely explained by the higher BSQ scores accompanying lipedema; this should not be interpreted as indicating that lipedema is unrelated to orthorexic tendencies. These findings support consideration of body image when addressing eating behavior in lipedema care.